News

Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...
The consumer privacy ombudsman tasked with analyzing the impact of 23andMe’s bankruptcy sale on individuals’ privacy has ...
A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 46th Annual Goldman Sachs Global Healthcare Conference June 9, 2025 10:40 AM ETCompany ...
Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 ...
By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...
The health industry witnesses significant developments as Hims & Hers acquires UK startup Zava, Sanofi plans a $9.5 billion ...
In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...
A key decision by the bankruptcy judge could help with protecting consumer data, write Diane Lourdes Dick and Anya Prince.